DAE

Abstract

We discuss the use of optimal model-based designs at different stages of drug development. Special attention is given to adaptive model-based designs in dose finding studies and designs for nonlinear mixed models which arise in population pharmacokinetic/pharmacodynamic studies. Examples of software tools and their application are provided